Journal article
'What is this active surveillance thing?' Men's and partners' reactions to treatment decision making for prostate cancer when active surveillance is the recommended treatment option
C O'Callaghan, T Dryden, A Hyatt, J Brooker, S Burney, AC Wootten, A White, M Frydenberg, D Murphy, S Williams, P Schofield
Psycho Oncology | Published : 2014
DOI: 10.1002/pon.3576
Abstract
Objective: In the past decade, localised prostate cancer (LPC) management has been shifting from three radical treatment options (radical prostatectomy, external beam radiotherapy, or brachytherapy) to also include active surveillance (AS). This study examines men with LPC and partners' experiences of choosing between AS and radical treatments, and their experiences of AS when selected. Methods: A qualitative descriptive research design was used. Interviewed participants were men, and partners of men, who either had chosen radical treatment immediately following diagnosis or had been on AS for at least 3 months. AS was the recommended treatment. Transcribed interviews were thematically analy..
View full abstractGrants
Awarded by Victorian Cancer Agency
Funding Acknowledgements
The authors thank the men and partners who participated in the study and also Emily Habgood, Nicole Kinnane, and Dr Ilona Juraskova for their assistance. This study was funded by the Victorian Cancer Agency as part of The Cancer of Prostate Translational Research in Victoria (CAPTIV) programme, grant code TSP11_02. Assistant Professor Schofield holds an NHMRC career development fellowship (CDA level 2). The research was approved by Human Research and Ethics Committees at Peter MacCallum Cancer Centre, Cabrini Health, and Royal Melbourne Hospital, Melbourne, Australia. No parts of this manuscript have been published elsewhere.